The global cardiac biomarker market is on the cusp of a remarkable surge in the coming years, fueled by the rising prevalence of cardiovascular diseases and the increasing need for accurate diagnosis and monitoring of heart conditions. According to a recent industry report, the market, valued at USD 15.87 billion in 2022, is expected to reach a staggering USD 48.21 billion by 2030,...